SMS Lifesciences India Ltd Financials
Company Logo

SMS Lifesciences India Ltd Financial Statement

SMS Lifesciences India Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue79.75
Operating Expense66.70
Net Profit6.01
Net Profit Margin7.54
Earning Per Share19.87
EBIDTA13.00
Effective Tax Rate19.14
Invest in SMS Lifesciences India Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

SMS Lifesciences India Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual300.00
Operating Expenses Annual265.57
Operating Profit Annual38.27
Interest Annual8.90
Depreciation9.56
Net Profit Annual13.07
Tax Annual6.05

SMS Lifesciences India Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.15
Cash Flow from Operations14.75
Cash Flow from Investing-13.75
Cash Flow from Financing-0.82
Cash Flow at the End0.33

SMS Lifesciences India Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)11.67
PBIT Margin (%)8.56
PBT Margin (%)7.61
Net PROFIT Margin (%)3.98
Return On Networth / Equity (%)7.68
Return On Networth /Employed (%)10.68
Return On Assets (%)4.97
Total Debt / Equity (X)0.53
Asset Turnover Ratio (%)1.25

SMS Lifesciences India Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual138.23
Total Current Assets Annual174.49
Non Current Assets Annual172.88
Total Shareholders Funds Annual176.23
Total Assets Annual347.38

SMS Lifesciences India Ltd Earning Calls

EPS (INR)

Expected

15.46

Reported

15.46

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by -0.13%

Dec 2023

EPS beaten by -0.05%

Get Your FAQs Right

As of Nov 25, 2024, SMS Lifesciences India Ltd has a market capitalization of 205.21 Cr. Value Research classifies it as a Small-Cap company.
No, SMS Lifesciences India Ltd is not debt-free with a debt-to-equity ratio of 0.52.
In FY 2023 , SMS Lifesciences India Ltd recorded a total revenue of approximately 300 Cr marking a significant milestone in the company's financial performance.
SMS Lifesciences India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and -0.1% annually, respectively..
SMS Lifesciences India Ltd's current PE ratio is 15.70.
SMS Lifesciences India Ltd's ROCE averaged 10.2% from the FY ending March 2022 to 2024, with a median of 10.5%. It peaked at 11.7% in March 2022, reflecting strong capital efficiency over the period..
SMS Lifesciences India Ltd's latest EBIT is Rs. 28.01 Cr, surpassing the average EBIT of Rs. 29.69 Cr over the 5 years..